Ibrance rejected for health insurance benefits

Published: 2017-06-13 16:29:00
Updated: 2017-06-13 09:59:59

The registration of Ibrance Cap(Pfizer Pharmaceuticals Korea), a breast cancer treatment, for the health insurance benefits fell through.

The Health Insurance Benefit Evaluation Committee conducted an health insurance benefit evaluation on 6 products of 5 companies on the 8th and decided the hea...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.

Original Korean




Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.